Cargando…

A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis

PURPOSE: Newborn screening (NBS) for cystic fibrosis (CF) can identify carriers, which is considered a benefit that enables reproductive planning. We examined the reproductive impact of carrier result disclosure from NBS for CF. METHODS: We surveyed mothers of carrier infants after NBS (Time-1) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bombard, Yvonne, Miller, Fiona A., Barg, Carolyn J., Patton, Sarah J., Carroll, June C., Chakraborty, Pranesh, Potter, Beth K., Tam, Karen, Taylor, Louise, Kerr, Elizabeth, Davies, Christine, Milburn, Jennifer, Ratjen, Felix, Guttmann, Astrid, Hayeems, Robin Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319861/ https://www.ncbi.nlm.nih.gov/pubmed/27608173 http://dx.doi.org/10.1038/gim.2016.125

Ejemplares similares

What's Involved with Wanting to Be Involved? Comparing Expectations for Public Engagement in Health Policy across Research and Care Contexts
por: Barg, Carolyn J., et al.
Publicado: (2017)

The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario
por: Kennedy, Shelley, et al.
Publicado: (2010)

Health-care providers’ perspectives on uncertainty generated by variant forms of newborn screening targets
por: Azzopardi, Paul J., et al.
Publicado: (2019)

What is in a Name? Parent, Professional and Policy-Maker Conceptions of Consent-Related Language in the Context of Newborn Screening
por: Nicholls, Stuart G, et al.
Publicado: (2019)

Factors associated with knowledge of and satisfaction with newborn screening education: a survey of mothers
por: Araia, Makda H., et al.
Publicado: (2012)

Building a Newborn Screening Information Management System from Theory to Practice
por: Pluscauskas, Michael, et al.
Publicado: (2019)

How digital tools can advance quality and equity in genomic medicine
por: Bombard, Yvonne, et al.
Publicado: (2020)

Parental Preferences for Expanded Newborn Screening: What Are the Limits?
por: Liang, Nicole S. Y., et al.
Publicado: (2023)

Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening
por: Khangura, Sara D., et al.
Publicado: (2021)

Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
por: Nicholls, S G, et al.
Publicado: (2014)

Policy Rogue or Policy Entrepreneur? The Forms and Impacts of “Joined-Up Governance” for Child Health
por: Cressman, Celine, et al.
Publicado: (2021)

Cross-sectional prospective feasibility study of newborn screening for sickle cell anaemia and congenital hypothyroidism in Guyana
por: Alladin, Bibi Areefa, et al.
Publicado: (2022)

Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening
por: Ulph, Fiona, et al.
Publicado: (2015)

Postnatal Prediction of Gestational Age Using Newborn Fetal Hemoglobin Levels
por: Wilson, Kumanan, et al.
Publicado: (2016)

Using newborn screening analytes to identify cases of neonatal sepsis
por: Fell, Deshayne B., et al.
Publicado: (2017)

Association between newborn screening analyte profiles and infant mortality
por: Fell, Deshayne B., et al.
Publicado: (2019)

Postnatal gestational age estimation via newborn screening analysis: application and potential
por: Wilson, Lindsay A., et al.
Publicado: (2019)

Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada
por: Karaceper, Maria D., et al.
Publicado: (2019)

Association Between Newborn Metabolic Profiles and Pediatric Kidney Disease
por: Sood, Manish M., et al.
Publicado: (2018)

Postnatal gestational age estimation using newborn screening blood spots: a proposed validation protocol
por: Murphy, Malia S Q, et al.
Publicado: (2017)

Association between newborn screening analytes and hypoxic ischemic encephalopathy
por: Wilson, Lindsay A., et al.
Publicado: (2019)

The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study
por: Karaceper, Maria D., et al.
Publicado: (2016)

Validation of gestational age determination from ultrasound or a metabolic gestational age algorithm using exact date of conception in a cohort of newborns conceived using assisted reproduction technologies
por: Hawken, Steven, et al.
Publicado: (2022)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)

Health system strategies supporting transition to adult care
por: Hepburn, Charlotte Moore, et al.
Publicado: (2015)

Letting It All Out: Neutrophils in Early Cystic Fibrosis Airway Inflammation
por: Perrem, Lucy, et al.
Publicado: (2019)

Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
por: White, Stephanie, et al.
Publicado: (2023)

Incidental screen positive findings in a prospective cohort study in Matlab, Bangladesh: insights into expanded newborn screening for low-resource settings
por: Murphy, Malia S. Q., et al.
Publicado: (2019)

Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges
por: Parker, Hilda, et al.
Publicado: (2007)

Factors affecting the growth of infants diagnosed with cystic fibrosis by newborn screening
por: Patterson, K. D., et al.
Publicado: (2019)

Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?
por: Thia, Lena P, et al.
Publicado: (2014)

External validation of postnatal gestational age estimation using newborn metabolic profiles in Matlab, Bangladesh
por: Murphy, Malia SQ, et al.
Publicado: (2019)

Stakeholder perspectives on clinical research related to therapies for rare diseases: therapeutic misconception and the value of research
por: Tingley, Kylie, et al.
Publicado: (2021)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
por: Dumas, Marie-Pier, et al.
Publicado: (2021)

A systematic review of the association between coping strategies and quality of life among caregivers of children with chronic illness and/or disability
por: Fairfax, Alana, et al.
Publicado: (2019)

L-Ornithine Derived Polyamines in Cystic Fibrosis Airways
por: Grasemann, Hartmut, et al.
Publicado: (2012)

The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
por: Shemie, Genevieve, et al.
Publicado: (2021)

Reasoning About Algebraic Structures with Implicit Carriers in Isabelle/HOL
por: Guttmann, Walter
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tl2tts0a3v6rpntsi0di85s6o5